GSTA1 and coronary artery disorder: Plasma levels of MDA, end product of lipid peroxidation, and established marker of lipid oxidative damage were analyzed in CAD-related HF patients stratified according to polymorphism in GSTA1 and GSTP1 antioxidant enzymes (Table 6).